Synthetic Bryostatin Available to Expand Neurodegenerative Indication Trials PR Newswire NEW YORK, Feb. 4, 2021 NEW YORK, Feb. 4, 2021...
Neurotrope and Metuchen Pharmaceuticals Announce Completion of Merger Forming Petros Pharmaceuticals - Petros to Grow and Pursue Non-Prescription...
NOTIFICATION OF REMOVAL FROM LISTING AND/OR REGISTRATION UNDER SECTION 12(b) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File...
FORM 4 [ ] Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction...
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.